Home World News Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to... World News Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to Experience Reservoir Decay with Anti-PD1 Therapy By Ogkologos - March 9, 2026 353 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from multiomic profiling in the CITN-12 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Results in Greater EFS and pCR... November 6, 2023 EMA Recommends Granting a Marketing Authorisation for Generic Arsenic Trioxide August 10, 2020 Single Mom Has To Beg For Rides To Doctor For Son... March 14, 2019 Researchers Discover Way to Help Immunotherapy Better Target Solid Tumors Like... January 5, 2021 Load more HOT NEWS RNF43 Mutations Warrant Further Validation for Potential to Prioritise Anti-EGFR/BRAF Combinations... For HPV-Positive Women, Test Can Guide Cervical Cancer Screening Follow-Up 5 ways cancer can impact sexual wellbeing ESMO Welcomes Draft Report on Europe’s Beating Cancer Plan (BCP) Which...
